PT  - JOURNAL ARTICLE
AU  - Pickrell, William Owen
AU  - Lacey, Arron S
AU  - Thomas, Rhys H
AU  - Smith, Philip E M
AU  - Rees, Mark I
TI  - Weight change associated with antiepileptic drugs
AID  - 10.1136/jnnp-2012-303688
DP  - 2013 Jul 01
TA  - Journal of Neurology, Neurosurgery & Psychiatry
PG  - 796--799
VI  - 84
IP  - 7
4099  - http://jnnp.bmj.com/content/84/7/796.short
4100  - http://jnnp.bmj.com/content/84/7/796.full
SO  - J Neurol Neurosurg Psychiatry2013 Jul 01; 84
AB  - Aim To investigate antiepileptic drug (AED)-related weight changes in patients with epilepsy through a retrospective observational study. Method We analysed the anonymised electronic primary care records of 1.1 million adult patients in Wales. We included patients aged 18 years and over with a diagnosis of epilepsy, whose body weight had been measured up to 12 months before starting, and between 3 and 12 months after starting, one of five AEDs. We calculated the weight difference after starting the AED for each patient. Results 1423 patients were identified in total. The mean difference between body weight after and before starting each AED (together with 95% CI and p values for no difference) were: carbamazepine (CBZ) 0.43 (−0.19 to 1.05) p=0.17; lamotrigine (LTG) 0.31 (−0.38 to 1.00) p=0.38; levetiracetam (LEV) 1.00 (0.16 to 1.84) p=0.02; sodium valproate (VPA) 0.74 (0.10 to 1.38) p=0.02; topiramate (TPM) −2.30 (−4.27 to −0.33) p=0.02. Conclusions LEV and VPA were associated with significant weight gain, TPM was associated with significant weight loss, and LTG and CBZ were not associated with significant weight change.